매상 변화 날짜
AbbVie USD 17.4B 410M 2026-09
Amgen USD 10.4B 300M 2026-09
AstraZeneca USD 16.21B 830M 2026-09
Biogen USD 2.8B 60M 2026-09
Bristol-Myers Squibb USD 13.07B 100M 2026-09
Daiichi Sankyo JPY 592.49B 17.75B 2026-09
Eli Lilly USD 24.4B 1.43B 2026-09
Genmab DKK 1.16B 259M 2026-06
Geron USD 60.19M 2.71M 2026-09
Gilead Sciences USD 8.3B 500M 2026-09
J&J USD 25.4B 89M 2026-09
Karyopharm Therapeutics USD 35.07M 987K 2026-03
MacroGenics USD 32.83M 12.03M 2026-06
Merck USD 18.1B 1.5B 2026-09
Pfizer USD 16.6B 1.57B 2026-09
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 5.12B 830M 2026-09
Roche Holding CHF 30.36B 14.71B 2026-06
Xencor USD 116.52M 65.3M 2026-09